Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
26th May 2026 Uncategorised 0
Findings strengthen rationale for EMERALD trial of engineered macrophage therapy RTX001

More: Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
Source: News
